NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Now that is funny. I can just see the PR:

"Red haired patients had a 37% survival at 53 months in the treatment arm compared to 14% in control (P<.2)"

There is a reason why subgroups are generally BS. Take enough different subsets and one will look good by random chance. Especially if you do not even care about stat sig.

When the FDA releases the guidance (probably late this year or early next) I would not be surprised to see them comment on this.